Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes
- 5 March 1991
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 194 (2-3) , 195-200
- https://doi.org/10.1016/0014-2999(91)90105-y
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Calcium Channel Receptor Binding Studies for Diltiazem and Its Major MetabolitesJournal of Cardiovascular Pharmacology, 1987
- [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortexEuropean Journal of Pharmacology, 1985
- Temperature‐dependent regulation of d‐cis‐[3H]diltiazem binding to Ca2+ channels by 1,4‐dihydropyridine channel agonists and antagonistsFEBS Letters, 1983
- Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomesBiochemical and Biophysical Research Communications, 1982
- Development of Diltiazem, A Calcium Antagonist: Coronary Vasodilating and Antihypertensive ActionsClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- (+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes.Published by Elsevier ,1978
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977